))
Chatter with BNC | Kevin O'Brien, President of Merz Therapeutics
Manage episode 404903206 series 3004501
Innehåll tillhandahållet av Business North Carolina. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Business North Carolina eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Welcome to Chatter with BNC, Business North Carolina's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people. Today's episode features an interview with Kevin O’Brien. O'Brien serves as president of North America for Merz Therapeutics, where he leads commercial strategy and execution, including field sales, managed markets, medical affairs, marketing and operations, across the U.S. and Canada. Since joining Merz in 2017, he has overseen the U.S. FDA approval of Merz’s neuromodulator for the treatment of sialorrhea (excessive drooling) and as a first-line treatment for blepharospasm, two debilitating conditions associated with neurological conditions, including Parkinson’s disease, ALS and cerebral palsy.
…
continue reading
101 episoder
Dela
